2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (10876):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W743936
    Fosaprepitant-d4 Dimeglumine
    Fosaprepitant-d4 Dimeglumine is the deuterium labeled Fosaprepitant Dimeglumine.
    Fosaprepitant-d<sub>4</sub> Dimeglumine
  • HY-113365S3
    Cholestenone-d7
    Cholestenone-d7 is deuterium labeled Cholestenone. Cholestenone (4-Cholesten-3-one), the intermediate oxidation product of cholesterol, is metabolized primarily in the liver. Cholestenone is highly mobile in membranes and influences cholesterol flip-flop
    Cholestenone-d<sub>7</sub>
  • HY-146946S
    D-Myo-phosphatidylinositol 3,4,5-trisphosphate diC16-d5
    D-Myo-phosphatidylinositol 3,4,5-trisphosphate diC16-d5 is deuterium labeled D-Myo-phosphatidylinositol 3,4,5-trisphosphate diC16.
    D-Myo-phosphatidylinositol 3,4,5-trisphosphate diC16-d<sub>5</sub>
  • HY-143560S
    3-(1-Nitrosopyrrolidin-2-yl)pyridine 1-oxide-d4
    3-(1-Nitrosopyrrolidin-2-yl)pyridine 1-oxide-d4 is the deuterium labeled 3-(1-Nitrosopyrrolidin-2-yl)pyridine 1-oxide (HY-W700113).
    3-(1-Nitrosopyrrolidin-2-yl)pyridine 1-oxide-d<sub>4</sub>
  • HY-B0370S
    Tolnaftate-d7
    Tolnaftate-d7 is the deuterium labeled Tolnaftate. Tolnaftate (NP-27) is a synthetic thiocarbamate used as an anti-fungal agent.
    Tolnaftate-d<sub>7</sub>
  • HY-W704014
    N-Nitroso-N-methyl-N-dodecylamine-d5
    N-Nitroso-N-methyl-N-dodecylamine-d5 (N-Methyl-N-nitroso-1-dodecanamine-d5) is the deuterium labeled N-Methyl-N-nitroso-1-dodecanamine (HY-W899995).
    N-Nitroso-N-methyl-N-dodecylamine-d<sub>5</sub>
  • HY-13062AS
    Daunorubicin-13C,d3 TFA
    Daunorubicin-13C,d3 TFA (Daunomycin-13C,d3 TFA) is the deuterium and 13C-labeled Daunorubicin TFA. Daunorubicin (Daunomycin) is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin inhibits DNA and RNA synthesis. Daunorubicin is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin is also an anthracycline antibiotic. Daunorubicin can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor.
    Daunorubicin-<sup>13</sup>C,d<sub>3</sub> TFA
  • HY-W702697
    α-Desmethyl anastrozole-d3
    α-Desmethyl anastrozole-d3 (alpha-Desmethyl anastrozole-d3) is the deuterium labeled α-Desmethyl anastrozole.
    α-Desmethyl anastrozole-d<sub>3</sub>
  • HY-W748349
    2,2',3,3',4,4',5,5'-Octachloro-1,1'-biphenyl-13C12
    2,2',3,3',4,4',5,5'-Octachloro-1,1'-biphenyl-13C12 is 13C labeled 2,2',3,3',4,4',5,5'-Octachloro-1,1'-biphenyl.
    2,2',3,3',4,4',5,5'-Octachloro-1,1'-biphenyl-<sup>13</sup>C<sub>12</sub>
  • HY-W723941
    2,3-Dichlorobenzoic acid-d3
    2,3-Dichlorobenzoic acid-d3 is the deuterium labeled 2,3-Dichlorobenzoic acid.
    2,3-Dichlorobenzoic acid-d<sub>3</sub>
  • HY-117660S1
    Lincomycin-13C,d3
    Lincomycin-13C,d3 (U-10149-13C,d3) is the deuterium and 13C-labeled Lincomycin (HY-117660). Lincomycin (U-10149) is an orally active lincosamide antibiotic. Lincomycin binds to the ribosomes of Gram-positive bacteria to inhibit protein synthesis. Lincomycin can inhibit chloroplast translation, disrupt chloroplast integrity, and activate chloroplast-to-nucleus retrograde signaling in Arabidopsis thaliana seedlings. Lincomycin induces alterations in lipid profiles and liver injury, disrupts blood glucose and insulin levels, and increases growth rate in mice.
    Lincomycin-<sup>13</sup>C,d<sub>3</sub>
  • HY-W751667
    1-Adamantyl Methyl Ketoxime-d3
    1-Adamantyl Methyl Ketoxime-d3 is the deuterium labeled 1-Adamantyl Methyl Ketoxime (HY-W751666).
    1-Adamantyl Methyl Ketoxime-d<sub>3</sub>
  • HY-114591S
    Spiromesifen-d9
    Spiromesifen-d9 is a deuterated labeled Spiromesifen. Spiromesifen (BSN 2060) is a broad-spectrum tetrachloro acid derivative acaricide. Spiromesifen can interfere with lipid biosynthesis, and has no cross-resistance to any resistant mite or whitefly populations.
    Spiromesifen-d<sub>9</sub>
  • HY-B1355AS1
    Oxyphenbutazone-13C6
    Oxyphenbutazone-13C6 is the 13C6 labeled Oxyphenbutazone (HY-B1355A). Oxyphenbutazone is a phenylbutazone derivative, with anti-inflammatory effect. Oxyphenbutazone is a non-selective COX inhibitor. Oxyphenbutazone is the metabolite of Phenylbutazone (HY-B0230). Oxyphenbutazone selectively kills non-replicating Mycobaterium tuberculosis.
    Oxyphenbutazone-<sup>13</sup>C<sub>6</sub>
  • HY-24385S1
    N-Nitrosodipropylamine-d7
    N-Nitrosodipropylamine-d7 is the deuterium labeled N-Nitrosodipropylamine.
    N-Nitrosodipropylamine-d<sub>7</sub>
  • HY-W094748S
    Dibenzo[b,e][1,4]dioxin-d8
    Dibenzo[b,e][1,4]dioxin-d8 is the deuterium labeled Dibenzo[b,e][1,4]dioxin.
    Dibenzo[b,e][1,4]dioxin-d<sub>8</sub>
  • HY-W740298
    1-(1-Naphthyl)ethylamine-d3
    1-(1-Naphthyl)ethylamine-d3 is the deuterium labeled 1-(1-Naphthyl)ethylamine (HY-75070A).
    1-(1-Naphthyl)ethylamine-d<sub>3</sub>
  • HY-B0124S3
    Zonisamide-15N,d4
    Zonisamide-15N,d4 is the 15N- and deuterium labeled Zonisamide (HY-B0124). Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy.
    Zonisamide-<sup>15</sup>N,d<sub>4</sub>
  • HY-W738480
    L-Phenylalanine tert-butyl ester-d5
    L-Phenylalanine tert-butyl ester-d5 ((R)-Tert-Butyl 2-amino-3-phenylpropanoate-d5) is the deuterium labeled (S)-tert-Butyl 2-amino-3-phenylpropanoate (HY-W108426).
    L-Phenylalanine tert-butyl ester-d<sub>5</sub>
  • HY-114376
    Borocaptate-10B12 sodium
    		98.35%
    Borocaptate-10B12 (BSH-10B12) sodium is a boron-10 labeled Borocaptate (HY-142041). Borocaptate sodium is a boron-containing compound that can be used as a therapeutic agent in boron neutron capture therapy (BNCT), exhibiting anticancer activity.
    Borocaptate-<sup>10</sup>B<sub>12</sub> sodium